Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma

Cancer Genetics and Cytogenetics

Volumn 170, Issue 2, 2006, Pages 140-146

  Li, Lin ^a   Gupta, Shiphali ^a   Bashir, Tayyaba ^a   Koduru, Prasad R ^a   Brody, Judith ^a   Allen, Steven L ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MEPREDNISONE; METHOTREXATE; RITUXIMAB; TOPOTECAN; VINCRISTINE;

ADULT; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; FOLLICULAR LYMPHOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LABORATORY TEST; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; TREATMENT OUTCOME;

BONE MARROW; BURKITT LYMPHOMA; CHROMOSOME ABERRATIONS; CHROMOSOME INVERSION; DISEASE PROGRESSION; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; INVERSION, CHROMOSOME; LYMPH NODES; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 33748958843     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.05.015     Document Type: Article

References (36)

1. Nathulani B.N., Harris N.L., Weisenberger D., Isaacson P.G., Piris M.A., Berger F., Millermelink H.K., and Swerdlow S.H. Follicular lymphoma. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours (2001), IARC Press, Lyon 162-167
2. Lossos I.S., and Levy R. Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 13 (2003) 191-202
3. Horning S.J., and Rosenberg S.A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311 (1984) 1471-1475
4. Bastion Y., Sebban C., Berger F., Felman P., Salles G., Dumontet C., Bryon P.A., and Coiffier B. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15 (1997) 1587-1594
5. Advani R., Rosenberg S.A., and Horning S.J. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. J Clin Oncol 22 (2004) 1454-1459
6. Yunis J.J., Frizzera G., Oken M.M., McKenna J., Theologides A., and Arnesen M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N Engl J Med 316 (1987) 79-84
7. Tilly H., Rossi A., Stamatoullas A., Lenormand B., Bigorgne C., Kunlin A., Monconduit A., and Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84 (1994) 1043-1049
8. Takeuchi S., de Vos S., Takeuchi N., Fermin A.C., Grogan T.M., Seo H., Said J.W., and Koeffler H.P. Allelic loss during progression of follicular lymphoma. Leuk Res 28 (2004) 567-569
9. Horsman D.E., Connors J.M., Pantzar T., and Gascoyne R.D. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 30 (2001) 375-382
10. Akasaka T., Lossos I.S., and Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 102 (2003) 1443-1448
11. Matolcsy A. High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression. Leuk Lymphoma 34 (1999) 251-259
12. Koduru P.R.K., and Offit K. Molecular structure of double reciprocal translocations: significance in B-cell lymphomagenesis. Oncogene 6 (1991) 145-148
13. Hurvitz S.A., and Timmerman J.M. Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId. Expert Opin Biol Ther 5 (2005) 841-852
14. Magrath I., Adde M., Shad A., Venzon D., Seibel N., Gootenberg J., Neely J., Arndt C., Nieder M., Jaffe E., Wittes R.A., and Horak I.D. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14 (1996) 925-934
15. ISCN 1995: an international system for human cytogenetic nomenclature (1995). In: Mitelman F. (Ed) (1995), S. Karger, Basel
16. Schmidt H.H., Pirc-Danoewinata H., Panzer-Grumayer E.R., Sill H., Sedlmayr P., Neumeister P., Linkesch W., and Haas O.A. Translocation (3;5)(p26;q13) in a patient with chronic T-cell lymphoproliferative disorder. Cancer Genet Cytogenet 104 (1998) 82-85
17. Nomura K., Kanda-Akano Y., Shimizu D., Okuda T., Yoshida N., Matsumoto Y., Nishida K., Taki T., Yokota S., Horiike S., and Taniwaki M. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma. Ann Hematol 84 (2005) 474-476
18. Aamot H., Micci F., Holte H., Delabie J., and Heim S. M-FISH cytogenetic analysis of non-Hodgkin lymphomas with t(14;18)(q32;q21) and add(1)(p36) as secondary abnormality shows that the extra material often comes from chromosome arm 17q. Leuk Lymphoma 43 (2002) 1051-1056
19. Polito P., Cilia A.M., Gloghini A., Cozzi M., Perin T., de Paoli P., Gaidano G., and Carbone A. High frequency of EBV association with non-random abnormalities of the chromosome region 1q21-25 in AIDS-related Burkitt's lymphoma-derived cell lines. Int J Cancer 61 (1995) 370-374
20. Garcia J.L., Hernandez J.M., Gutierrez N.C., Flores T., Gonzalez D., Calasanz M.J., Martinez-Climent J.A., Piris M.A., Lopez-Capitan C., Gonzalez M.B., Odero M.D., and San Miguel J.F. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma: a cytogenetic and comparative genomic hybridization study. Leukemia 17 (2003) 2016-2024
21. Berger R., Coniat M.L., Derre J., and Vecchione D. Secondary nonrandom chromosomal abnormalities of band 13q34 in Burkitt lymphoma-leukemia. Genes Chromosomes Cancer 1 (1989) 115-118
22. Cavazzini F., Cuneo A., de Angeli C., Bardi A., Agostini P., Tammiso E., Rigolin G.M., and Castoldi G. Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia. Leuk Lymphoma 45 (2004) 1197-1203
23. Yamamoto K., Okamura A., Minagawa K., Yakushijin K., Urahama N., Gomyo H., Shimoyama M., Itoh M., and Matsui T. A novel t(2;6)(p12;q23) appearing during transformation of follicular lymphoma with t(18;22)(q21;q11) to diffuse large cell lymphoma. Cancer Genet Cytogenet 147 (2003) 128-133
24. Elenitoba-Johnson K.S.J., Gascoyne R.D., Lim M.S., Chhanabai M., Jaffe E.S., and Raffeld M. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 91 (1998) 4677-4685
25. Blum K.A., Lozanski G., and Byrd J.C. Adult Burkitt leukemia and lymphoma. Blood 104 (2004) 3009-3020
26. Diebold J., Jaffe E.S., Raphael M., and Warnke R.A. Burkitt lymphoma. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours (2001), IARC Press, Lyon 181-184
27. Yano T., Jaffe E.S., Longo D.L., and Raffeld M. MYC rearrangements in histologically progressed follicular lymphoma. Blood 80 (1992) 758-767
28. Lee J.T., Innes Jr. D.J., and Williams M.E. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest 84 (1989) 1454-1459
29. Arcinas M., Heckman C.A., Mehew J.W., and Boxer L.M. Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma. Cancer Res 61 (2001) 5202-5206
30. Fiedler W., Weh H.J., Zeller W., Fonatsch C., Hillion J., Larsen C., Wormann B., and Hossfeld D.K. Translocation (14;18) and (8;22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma. Ann Hematol 63 (1991) 282-287
31. Raghoebier S., Broos L., Kramer M.H., van Krieken J.H.J.M., Kluin-Nelemans J.C., van Ommen G.J.B., and Kluin P.H.M. Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes. Leukemia 9 (1995) 1748-1755
32. Gauwerky C.E., Hoxie J., Nowell P.C., and Croce C.M. Pre-B-cell leukemia with a t(8;14) and a t(14;18) translocation is preceded by follicular lymphoma. Oncogene 2 (1988) 431-435
33. Au W.Y., Horsman D.E., Gascoyne R.D., Viswanatha D.S., Klasa R.J., and Connors J.M. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 45 (2004) 519-528
34. Williams M.E., Swerdlow S.H., Rosenberg C.L., and Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7 (1993) 241-245
35. Lamant L., Dastugue N., Pulford K., Delsol G., and Mariame B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 93 (1999) 3088-3095
36. Cazzaniga G., Tosi S., Aloisi A., Giudici G., Daniotti M., Pioltelli P., Kearney L., and Biondi A. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts. Blood 94 (1999) 4370-4373